Abstract
In childhood malignancies such as retinoblastoma and Wilms tumour, of which both familial and sporadic forms exist, recessive mutations of presumed differentiation genes have been implicated in tumorigenesis1,2. A proportion of cases appear with microscopically visible chromosome deletions which indicate the regions where the genes concerned are located. Mutation or loss of one allele causes a cancer predisposition. For tumour development functional loss of the remaining normal allele is also required. In cancers with both familial and sporadic forms, molecular-genetic studies have shown that deletion is often one of the mutational events2–5.Although familial and sporadic forms have never been distinguished in lung cancer, deletions of the short arm of chromosome 3 have been described for small cell lung cancer (SCLC) (refs 6, 7), but their general occurrence in SCLC has been disputed8–10. Using a molecular-genetic approach, we here present evidence for a consistent deletion at the chromosomal region 3p21, not only in SCLC11, but in all major types of lung cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. Knudson, A. G. Cancer Res. 45, 1437–1443 (1985). 2. Cavenee, W. K., Koufos, A. & Hansen, M. F. Mutat. Res. 168, 3–14 (1986). 3. Seizinger, B. R., Martuza, R. L. & Gusella, F. J. Nature 322, 644–647 (1985). 4. Zbar, B., Brauch, H., Talmadge, C. & Linehan, M. Nature 327, 721–724 (1987). 5. Solomon, E. et al Nature 328, 616–619 (1987). 6. Whang-Peng, J. et al. Cancer Genet. Cytogenet. 6, 119–134 (1982). 7. De Leij, L. et al. Cancer Res. 45, 6024–6033 (1985). 8. Wurster-Hill, D. H. et al. Cancer Genet. Cytogenet. 13, 303–330 (1984). 9. Zech, L., Bergh, J. & Nilsson, K. Cancer Genet. Cytogenet. 15, 335–347 (1985). 10. Morstijn, G. et al. Cancer Res. 45, 3322–3327 (1987). 11. Mooibroek, H., Osinga, J., Postmus, P. E., Carritt, B. & Buys, C. H. C. M. Cancer Genet. Cytogenet. 27, 361–366 (1987). 12. Donlon, T. A. & Magenis, R. E. HGM7 Cytogenet. Cell Genet. 37, 454 (1984). 13. Carritt, B., Welch, H. M. & Parry-Jones, N. J. Am. J. hum. Genet. 38, 428–436 (1986). 14. Goode, M. E., van Tuinen, P., Ledbetter, D. H. & Daiger, S. P. Am. J. hum. Genet. 38, 437–446 (1986). 15. Buys, C. H. C. M. et al. Eur. J. resp. Dis., Suppl. 70, 29–36 (1987). 16. Driesel, A. J. et al. HGM8 Cytogenet. Cell Genet. 40, 620 (1985). 17. Cavenee, W. K., Leach, P. J., Mohandas, T., Pearson, P. L. & White, R. Am. J. hum. Genet. 36, 10–24 (1984). 18. Naylor, S. L., Johnson, B., Minna, J-. D. & Sakaguchi, A. 7th Int. Cong. hum. Genet. Abstr. 560 (1986). 19. Whang-Peng, J. et al. Cancer Genet. Cytogenet. 11, 91–106 (1984). 20. Panani, A. & Ferti-Passantonopoulou, A. Cancer Genet. Cytogenet. 16, 65–71 (1985). 21. Muleris, M., Salmon, R.-J., Girodet, J., Zafrani, B. & Dutrillaux, B. Int. J. Cancer 39, 595–598 (1987). 22. Pathak, S., Strong, L. C., Ferrell, R. E. & Trinidade, A. Science 217, 939–941 (1982). 23. Wang, N. & Perkins, K. L. Cancer Genet. Cytogenet. 11, 497–481 (1984). 24. Carroll, P. R. et al. Cancer Genet. Cytogenet. 26, 253–259 (1987). 25. Willard, H. F., Skolnick, M. H., Pearson, P. L. & Mandel, J.-L. HGM8 Cytogenet. Cell Genet. 40, 360–489 (1985). 26. Ramaekers, F. et al. Histochem. J. 15, 691–713 (1983). 27. De Leij, L. et al. Cancer Res. 45, 2192–2200 (1985). 28. Buys, C. H. C. M., Koerts, T. & van der Veen, A. Y. Hum. Genet. 66, 361–364 (1984). 29. Harper, M. E. & Saunders, G. F. Chromosoma 83, 431–439 (1981). 30. Church, G. M. & Gilbert, W. Proc. natn. Acad. Sci. U.S.A. 81, 1991–1995 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kok, K., Osinga, J., Carritt, B. et al. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330, 578–581 (1987). https://doi.org/10.1038/330578a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/330578a0
This article is cited by
-
Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications
Cancer Gene Therapy (2022)
-
Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity
British Journal of Cancer (2017)
-
Clinical utility of RASSF1A methylation in human malignancies
British Journal of Cancer (2015)
-
Charles Buys (1942–2014)
European Journal of Human Genetics (2014)
-
Novel strategies for the treatment of small-cell lung carcinoma
Nature Reviews Clinical Oncology (2011)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.